Pillstats
Rx only · Tablet · Oral

Carbidopa

Brands: Lodosyn · Carbidopa

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers8 labelers
Packages10
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 4 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.212$0.424$0.637$0.849Dec 2025Apr 2026Jul 2026
$0.591
Latest avg · Jul 22, 2026
-20%
Since Dec 17, 2025
8
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1202403614812025 Q12025 Q22025 Q32025 Q42026 Q1
418
Rx · 2026 Q1
68K
Units dispensed
+11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novel Laboratories, Inc.unknown3SUPPLYING
Edenbridge Pharmaceuticals LLC.unknown1SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
Bausch Health US, LLCunknown1SUPPLYING
Lupin Pharmaceuticals,Inc.unknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.